Immunai, a startup developing an AI platform for biomarker discovery, has raised $60 million in venture funding.
View Article on VentureBeat
AI,Big Data,Cloud,Dev,Enterprise,VB Home Page,ai,artificial intelligence,biomarkers,category-/Business & Industrial/Pharmaceuticals & Biotech,category-/Health/Health Foundations & Medical Research,category-/Science,funding daily,Immunai,immunology,immunotherapy,machine learning
Big Data